Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers

doi:10.1186/1746-1596-3-6

Diagnostic Pathology

Volume 3

Viewing options:

Abstract
Full text
PDF (1.1MB)

Associated material:

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Fadare O
Zheng W

on PubMed

Fadare O
Zheng W
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Review

Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers

Oluwole Fadare¹^,2 and Wenxin Zheng³^,4

¹Department of Pathology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas, USA

²Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

³Department of Pathology, Department of Obstetrics and Gynecology, and the Arizona Cancer Center, University of Arizona College of Medicine, Tucson, Arizona, USA

⁴Department of Pathology and Hospital of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, China

author email corresponding author email

Diagnostic Pathology 2008, 3:6doi:10.1186/1746-1596-3-6


Published:	8 February 2008

Abstract

In this article, the authors briefly review the historical evolution of the various putative precursor lesions for Type II endometrial cancers, with an emphasis on the newly defined "Endometrial Glandular Dysplasia (EmGD)". The evidentiary basis for delineating serous EmGD as the most probable precursor lesions to endometrial serous carcinoma is reviewed in detail. An argument is advanced for the discontinuation of the term serous "endometrial intraepithelial carcinoma (EIC)" as a descriptor for a supposedly intraepithelial, precancerous lesion. Preliminary evidence is also presented that suggests that there is a morphologically recognizable "clear cell EmGD" that probably represents a precancerous lesion to endometrial clear cell carcinomas.